Abstract
The aims of this study were to evaluate: (1) the prevalence and types of potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension, and (2) whether or not differences in the training of primary care physicians were associated with potentially inappropriate prescribing. Primary care prescriptions issued by family physicians and general practitioners were audited using Screening Tool of Older Persons' Prescriptions criteria (version 1), with 18 out of 65 applicable criteria. Descriptive statistics were used to test the difference between proportions, and two-tailed t test was used for continuous variables. A total of 2,090 outpatient prescriptions were written during the study period; of these, 712 (34.1%) were potentially inappropriate. The mean number of drugs per patient was 6.03 (±2.5). Of the 712 prescriptions, 543 (76.3%) were used for the treatment of acute medical illnesses. The most common examples of potentially inappropriate prescribing were: orphenadrine (n = 174; 8.33%), long-term nonsteroidal anti-inflammatory drugs for > 3 months (n = 150; 7.18%), proton pump inhibitors for > 8 weeks (n = 135; 6.46%), antihypertensive therapy duplication (n = 59; 2.82%), long-acti...Continue Reading
References
Dec 7, 2002·Quality & Safety in Health Care·S M CampbellM Marshall
Oct 9, 2003·Scandinavian Journal of Primary Health Care·Heli TähepoldAtie van den Brink-Muinen
Oct 14, 2006·Journal of the American Geriatrics Society·Michael A SteinmanPeter J Kaboli
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Apr 22, 2008·Postgraduate Medical Journal·K A J Al KhajaA H H Damanhori
Jun 9, 2009·BMC Gastroenterology·Sebastian StraubeHenry J McQuay
Oct 9, 2009·Quality & Safety in Health Care·N D BarberA G Zermansky
Dec 17, 2009·British Journal of Clinical Pharmacology·Cristín RyanStephen Byrne
Jul 16, 2010·Journal of Evaluation in Clinical Practice·Ravishankar RamaswamyBarbara Roehl
Jul 7, 2011·Journal of Clinical Pharmacy and Therapeutics·V MaioS Del Canale
Mar 2, 2012·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society 2012 Beers Criteria Update Expert Panel
May 31, 2012·Drugs & Aging·Marie N O'ConnorDenis O'Mahony
Aug 7, 2012·European Journal of Internal Medicine·Eva Rocío Alfaro LaraBernardo Santos-Ramos
Apr 5, 2013·Journal of Clinical Pharmacy and Therapeutics·B Hill-TaylorR Christie
Apr 26, 2014·PloS One·Sandra Vezmar KovačevićBranislava Miljković
Oct 18, 2014·Age and Ageing·Denis O'MahonyPaul Gallagher
Feb 14, 2015·Journal of Evaluation in Clinical Practice·Márcio Galvão OliveiraLuiz Carlos Santana Passos
Aug 19, 2015·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Po-Jen YangMeng-Chih Lee
Sep 27, 2015·European Journal of Clinical Pharmacology·Khedidja HednaStaffan Hägg
Dec 4, 2015·BMC Geriatrics·Olivia DalleurAnne Spinewine
Mar 19, 2016·Journal of Clinical Pharmacy and Therapeutics·B Hill-TaylorI S Sketris
Aug 11, 2016·Geriatrics & Gerontology International·Gulistan BahatMehmet Akif Karan
Dec 3, 2016·PloS One·Encarnación Blanco-ReinaGabriel Ariza-Zafra
Feb 27, 2017·BMJ Open·Cia Sin Lee, Tau Ming Liew
Citations
Apr 26, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Rasha M ArabyatKarem H Alzoubi
Aug 20, 2020·The International Journal of Pharmacy Practice·Thananan Rattanachotphanit, Onanong Waleekhachonloet
Jan 4, 2020·Journal of Evaluation in Clinical Practice·Sule A SakaOlatunde Odusan
May 22, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Muhammad SaqlainFaizan Mazhar
Dec 4, 2020·British Journal of Clinical Pharmacology·Monika Pury OktoraPetra Denig